MCMC Methods for Parameter Estimation in ODE Systems for CAR-T Cell Cancer Therapy.

Simple Summary: Chimeric antigen receptor (CAR)-T cell therapy is a promising treatment for highly resistant blood cancers, using genetically modified T cells from the patient or a donor. While CAR-T therapy has been successful in pre-clinical and clinical stages for cancer treatment, it also presen...

Descripción completa

Detalles Bibliográficos
Publicado en:Cancers Vol. 16; no. 18; pp. 3132 - 3153
Autores principales: Antonini, Elia, Mu, Gang, Sansaloni-Pastor, Sara, Varma, Vishal, Kabak, Ryme
Formato: equations & formulas research tables/charts Journal Article
Publicado: MDPI Sep2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=180008809&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 180008809
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20726694
        B74B
      jtl: Cancers
      issn: 20726694
      maglogo: N
    pubinfo:
      dt: Sep2024
      vid: 16
      iid: 18
      pid: 97109
      pub: MDPI
    artinfo:
      ui:
        180008809
        180008809
        180008809
        10.3390/cancers16183132
        180008809
      ppf: 3132
      ppct: 21
      formats:
      tig:
        atl: MCMC Methods for Parameter Estimation in ODE Systems for CAR-T Cell Cancer Therapy.
      aug:
        au:
          Antonini, Elia
          Mu, Gang
          Sansaloni-Pastor, Sara
          Varma, Vishal
          Kabak, Ryme
        affil: Cilag GmbH International, 6300 Zug, Switzerland
      sug:
        subj:
          Hematologic Neoplasms Drug Therapy
          Cell Therapy Methods
          T Lymphocytes Transplantation
          Cytokine Release Syndrome Prevention and Control
          Genetic Engineering Methods
          Algorithms Evaluation
          Human
          Cell Proliferation
          Probability
          Models, Statistical Evaluation
          Data Analysis Software
          Treatment Outcomes Evaluation
          Prediction Models
      ab: Simple Summary: Chimeric antigen receptor (CAR)-T cell therapy is a promising treatment for highly resistant blood cancers, using genetically modified T cells from the patient or a donor. While CAR-T therapy has been successful in pre-clinical and clinical stages for cancer treatment, it also presents challenges, including cytokine release syndrome. To improve the efficacy and reduce side effects, there is a need to better understand CAR-T cell behavior. We aimed to develop a mathematical framework that describes CAR-T behavior using ordinary differential equations (ODEs) and Bayesian parameter estimation (using advanced algorithms including Metropolis–Hastings, DEMetropolis, and DEMetropolisZ). This model will help to understand CAR-T behavior and, by extension, help to improve the effectiveness and efficacy of therapy in a clinical setting. Chimeric antigen receptor (CAR)-T cell therapy represents a breakthrough in treating resistant hematologic cancers. It is based on genetically modifying T cells transferred from the patient or a donor. Although its implementation has increased over the last few years, CAR-T has many challenges to be addressed, for instance, the associated severe toxicities, such as cytokine release syndrome. To model CAR-T cell dynamics, focusing on their proliferation and cytotoxic activity, we developed a mathematical framework using ordinary differential equations (ODEs) with Bayesian parameter estimation. Bayesian statistics were used to estimate model parameters through Monte Carlo integration, Bayesian inference, and Markov chain Monte Carlo (MCMC) methods. This paper explores MCMC methods, including the Metropolis–Hastings algorithm and DEMetropolis and DEMetropolisZ algorithms, which integrate differential evolution to enhance convergence rates. The theoretical findings and algorithms were validated using Python and Jupyter Notebooks. A real medical dataset of CAR-T cell therapy was analyzed, employing optimization algorithms to fit the mathematical model to the data, with the PyMC library facilitating Bayesian analysis. The results demonstrated that our model accurately captured the key dynamics of CAR-T cell therapy. This conclusion underscores the potential of parameter estimation to improve the understanding and effectiveness of CAR-T cell therapy in clinical settings.
      pubtype: Academic Journal
      doctype:
        equations & formulas
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N